＜＜Back

Next＞＞

Vol. 34　Suppl. 1　2006

Phase I clinical study of solifenacin succinate
─Single oral administration study─

T.Tanaka, et al．

Jpn Pharmacol Ther 2006　34(s1) s5-13

---

Phase I clinical study of solifenacin succinate
─Multiple oral administration study─

T.Tanaka, et al．

Jpn Pharmacol Ther 2006　34(s1) s15-27

---

Clinical pharmacokinetic study of solifenacin succinate
─Non-blinded multiple oral dose study in healthy elderly and non-elderly male and female subjects─

M. Suzuki, et al.

Jpn Pharmacol Ther 2006　34(s1) s29-40

---

Clinical pharmacokinetic study of solifenacin succinate
─Study of food effect on the solifenacin pharmacokinetics─

T. Tanaka, et al.

Jpn Pharmacol Ther 2006　34(s1) s41-45

---

Solifenacin succinate phase II clinical trial
─Dose-finding study:A randomized, double-blind, placebo-controlled, parallel-group, fix-dose study in which 2.5, 5 and 10 mg of solifenacin succinate, or placebo are orally administered for 6 weeks to outpatients with overactive bladder ─

O. Yamaguchi, et al.

Jpn Pharmacol Ther 2006　34(s1) s47-68

---

Long-term safety and efficacy of solifenacin succinate in patients with overactive bladder

O. Yamaguchi, et al.

Jpn Pharmacol Ther 2006　34(s1) s69-86